Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 24 for “"Collateral sensitivity"”.
-
Understanding collateral sensitivity in the malaria parasite
… where resistance to one drug induces hypersensitivity to another drug, is known as 'collateral sensitivity'. It is believed that this collateral sensitivity could be exploited to delay or prevent the emergence of resistance to antimalarials. The overarching aim of this project was to …
-
Collateral sensitivity and the evolution of drug resistance in Escherichia coli
Recently, collateral sensitivity networks have created excitement for designing new therapies that could reduce rates of evolution of antibiotic resistance in pathogens. To explore this idea, I tested the key assumption that collateral sensitivity should reduce the frequency of mutation to …
-
Collateral Sensitivity Associated with Multidrug-Resistance Protein 5 in Triple-Negative Breast Cancer
… evidence. However, ABC transporters-associated collateral sensitivity (CS) is poorly understood and contributes to a promising novel therapeutic strategy to overcome MDR in breast cancer. In this study, we investigated olaparib accumulation and sensitivity in ABCC5-overexpressing HEK293 …
-
Mechanistic Dissection of a Collateral Sensitivity to Drug Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
… of drug resistance itself. Although these “collateral” sensitivities have long been documented in the microbial literature, details of their therapeutic relevance in cancer had, until recently, been limited to isolated reports. A previous, unpublished study of ours found that collateral …
-
Profiling of FDA-Approved and Clinical Trial Drugs Revealed Shared Cytotoxicity And Collateral Sensitivity In Resistant (H69ar) And Non-Resistant (H69) Small Cell Lung Cancer Cells. (Drug Repurposing in Cancer Chemotherapy)
… certain drugs are selectively cytotoxic (exhibit collateral sensitivity) to MRP1-overexpressed SCLC (H69AR) cells. In this study, three drugs (Erlotinib, Pyrimethamine, Fludarabine) were identified to exhibit a dose-dependent collateral sensitivity on H69AR with IC50 values of ~3.5 μM, ~2 μM, and …
-
Leveraging Gene by Environment (GxE) Interactions of Antimicrobial Resistant Escherichia coli
… antagonistic evolutionary trade-offs – namely collateral sensitivity – could be leveraged to constrain the emergence of drug- and multidrug-resistance. Across three studies, I combined experimental evolution, whole genome sequencing, phenotypic assays, and high-throughput transposon insertion …
-
Microbial interactions and evolution in antibiotic resistance profiles in organisms involved in cystic fibrosis infection
… novel therapeutic approaches. In this endeavor, collateral sensitivity (CS), the phenomenon in which resistance to one antibiotic promotes vulnerability to another, has recently received significant attention. Beyond antibiotic resistance, the intricate interaction among multiple pathogens during …
-
Antimicrobial peptide resistance: infection dynamics, cross-sensitivity to insect immune effectors, and evolution of pharmacodynamic
… knockdown study was performed to investigate the collateral sensitivity of AMP-resistant pathogen towards the host’s other immune effectors. The results highlighted that AMP-selected S. aureus strains are cross-sensitive towards phenoloxidase dependent immune responses, except the nsa-rpo mutants, …
-
Structure-function studies of multidrug resistance transporters of the malaria parasite
… with the development of multidrug resistance and collateral sensitivity - the phenomenon whereby acquiring resistance to one drug results in concomitant sensitivity to a second drug - in the malaria parasite. However, the mechanisms by which PfCRT and PfMDR1 modulate the parasite's susceptibility …
-
Contribution of Ionophores to Clinical Antimicrobial Resistance
… was found in S.epidermidis, but not in S.aureus. Collateral sensitivity and cross-resistance were also found in S.epidermidis, while S.aureus showed only a decrease in sensitivity toward some MIAs.
-
Molecular analysis of DNA damage induced by a novel trinuclear platinum complex (BBR 3464)
… to cisplatin was generally observed, an a collateral sensitivity or a very modest cross-resistance to BBR 3464 was found in OAW42Mer and A2780cp8 cell lines, respectively. Loss of mismatch repair proteins (hMLHl, hPMS2) or overexpression of nucleotide excision repair proteins (ERCC1) was …
-
Evolution of Targeted Therapy Resistance in EML4-ALK Positive Non-Small Cell Lung Cancer
… unique vulnerabilities that can be targeted with collateral sensitivity agents before full resistance evolves. These conclusions, obtained from in vitro studies, are applicable to the evolution of resistance in vivo. However, the evolution of resistance in vivo is also strongly influenced by …
-
A novel synthesis of dillapiol and its derivatives and their role as chemosensitizers and insecticide synergists.
… drug-sensitive AUXB1 cell line. The so-called collateral sensitivity of drug-resistant tumor cells to an otherwise benign lignan compound makes dillapiol an ideal candidate for an adjuvant in chemotherapy. Examination of the toxicity of dillapiol revealed no negative effects with respect to …
-
An evolutionary perspective on antibiotic treatment and the spread of resistance
… cross-effects and conserved patterns of collateral sensitivity between antibiotics. To answer these questions, I combine methods in microbiology, antimicrobial susceptibility testing, experimental evolution, molecular biology, genomics, advanced statistics and insights from mathematical …
-
CROSS-RESISTANCE OF ANTI-CANCER DRUGS: FRAMEWORK DEVELOPMENT AND QUANTIFICATION IN TWO IN VITRO MODELS OF CANCER
… approach led to detection and quantification of collateral sensitivity, where resistance to one drug makes cells vulnerable to a 2nd drug. Second, we conducted a HTS study to compute cross-resistance for a 414 cancer drug library in in-vitro melanoma and NSCLC models. Finally, we calculated …
-
Evolutionary Strategies Against Antimicrobial Resistance
… platforms tested. One such trade-off, collateral sensitivity (CS), has recently been proposed to be useful in mitigating resistance in sequential antibiotic therapies, where antibiotics are applied one after the other. But large-scale evolutionary studies to determine its role and …
-
Characterisation of Colorectal Cancer Cell Line LoVo and Drug-Adapted LoVo Cell Lines
… assays were done to show cross-resistance or collateral sensitivity in the drug-adapted cell lines to the drugs being tested (5-FU, irinotecan, oxaliplatin, miyabeacin, I-BET, JQ1, rucaparib, Olaparib, and verapamil) in comparison to the parental LoVo cell line. This assay can show which drugs …
-
Targeting Vulnerabilities in Cell State and Calcium Signaling for the Treatment of Lung Cancer
… MTI-101. Acquired resistance was found to have collateral sensitivity to standard of care agents while used as single agents and synergistic activity on wildtype cancer cells when used in combination with MTI-101. Simultaneous activation of second messengers calcium and cAMP alluded toward GPCR …
-
Evolution, Virulence, and Resistance in Chronic Pseudomonas aeruginosa Infection
… in these populations often displayed increased sensitivity to antimicrobials, even in cases where strains had been subject to treatment by the same antibiotic within the patient. There was poor evidence for either collateral sensitivity or trade-offs between AMR and fitness in these populations, …
-
Development of effective anti-cancer agents targeting drug-resistant malignancies
… cells exposed to CXL017 for 4 months develop collateral sensitivity towards a variety of standard therapies. Mechanistic investigations suggests that the re-sensitization observed in drug-resistant cells exposed to CXL017 is caused due to the down-regulation of Mcl-1 and a decrease in ER …
Page 1 of 2